Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Escherichia coli from biopsies differ in virulence genes between patients with colorectal neoplasia and healthy controls

J. Bosák, D. Kohoutová, M. Hrala, J. Křenová, P. Morávková, S. Rejchrt, J. Bureš, D. Šmajs

. 2023 ; 14 (-) : 1141619. [pub] 20230413

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23009990

INTRODUCTION: Pathogenic strains of Escherichia coli have been clearly identified as the causative agents of extraintestinal and diarrheal infections; however, the etiopathogenic role of E. coli in other conditions, including colorectal cancer, remains unclear. METHODS: This study aimed to characterize mucosal E. coli isolates (n = 246) from 61 neoplasia patients and 20 healthy controls for the presence of 35 genetic determinants encoding known virulence factors. RESULTS: Virulence determinants encoding invasin (ibeA), siderophore receptor (iroN), S-fimbriae (sfa), and genotoxin (usp) were more prevalent among E. coli isolated from patients with neoplasia compared to the control group (p < 0.05). In addition, the prevalence of these virulence determinants was increased in more advanced neoplasia stages (padj < 0.0125). Compared to patients with advanced colorectal adenoma and carcinoma, the ibeA gene was rarely found in the control group and among patients with non-advanced adenoma (p < 0.05), indicating its potential as the advanced-neoplasia biomarker. Patients with neoplasia frequently had E. coli strains with at least one of the abovementioned virulence factors, whereby specific combinations of these virulence factors were found. DISCUSSION: These findings suggest that E. coli strains isolated from patients with colorectal neoplasia possess several virulence factors, which could contribute to the development of neoplastic processes in the large intestine.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009990
003      
CZ-PrNML
005      
20230721095355.0
007      
ta
008      
230707s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fmicb.2023.1141619 $2 doi
035    __
$a (PubMed)37125208
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bosák, Juraj $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia
245    10
$a Escherichia coli from biopsies differ in virulence genes between patients with colorectal neoplasia and healthy controls / $c J. Bosák, D. Kohoutová, M. Hrala, J. Křenová, P. Morávková, S. Rejchrt, J. Bureš, D. Šmajs
520    9_
$a INTRODUCTION: Pathogenic strains of Escherichia coli have been clearly identified as the causative agents of extraintestinal and diarrheal infections; however, the etiopathogenic role of E. coli in other conditions, including colorectal cancer, remains unclear. METHODS: This study aimed to characterize mucosal E. coli isolates (n = 246) from 61 neoplasia patients and 20 healthy controls for the presence of 35 genetic determinants encoding known virulence factors. RESULTS: Virulence determinants encoding invasin (ibeA), siderophore receptor (iroN), S-fimbriae (sfa), and genotoxin (usp) were more prevalent among E. coli isolated from patients with neoplasia compared to the control group (p < 0.05). In addition, the prevalence of these virulence determinants was increased in more advanced neoplasia stages (padj < 0.0125). Compared to patients with advanced colorectal adenoma and carcinoma, the ibeA gene was rarely found in the control group and among patients with non-advanced adenoma (p < 0.05), indicating its potential as the advanced-neoplasia biomarker. Patients with neoplasia frequently had E. coli strains with at least one of the abovementioned virulence factors, whereby specific combinations of these virulence factors were found. DISCUSSION: These findings suggest that E. coli strains isolated from patients with colorectal neoplasia possess several virulence factors, which could contribute to the development of neoplastic processes in the large intestine.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kohoutová, Darina $u Center of Biomedical Research, University Hospital Hradec Králové, Hradec Králové, Czechia $u The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
700    1_
$a Hrala, Matěj $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Křenová, Jitka $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Morávková, Paula $u Second Department of Internal Medicine - Gastroenterology, Charles University, Faculty of Medicine in Hradec Králové, University Hospital Hradec Králové, Hradec Králové, Czechia
700    1_
$a Rejchrt, Stanislav $u Center of Biomedical Research, University Hospital Hradec Králové, Hradec Králové, Czechia
700    1_
$a Bureš, Jan $u Center of Biomedical Research, University Hospital Hradec Králové, Hradec Králové, Czechia
700    1_
$a Šmajs, David $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia
773    0_
$w MED00181714 $t Frontiers in microbiology $x 1664-302X $g Roč. 14, č. - (2023), s. 1141619
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37125208 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095348 $b ABA008
999    __
$a ok $b bmc $g 1958589 $s 1196254
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 14 $c - $d 1141619 $e 20230413 $i 1664-302X $m Frontiers in microbiology $n Front Microbiol $x MED00181714
LZP    __
$a Pubmed-20230707

Najít záznam

Citační ukazatele

Možnosti archivace